Transgender Research and Medicine SIG

Collaborative webinar presented by Oncoendocrinology SIG and Transgender Research & Medicine SIG  

Date: January 4, 2024 
Time: 12:00 to 1:30 PM ET 

Moderator: Ole-Petter R. Hamnvik, MB, BCh, BAO 
Case Presenters: Tugce Akcan, MD; and Ling Zhu, MB, BChir   
Expert Discussants: Ann Partridge, MD, MPH; Alexi Wright, MD, MPH; and Koen M. A. Dreijerink, MD, PhD

Description: As increasing numbers of transgender and gender diverse patients are seeking gender-affirming hormone treatment, more patients are needing to balance the risks and benefits of such treatment in the setting of known or newly diagnosed sex hormone-sensitive cancers (for example breast cancer and cancers of the reproductive tract). In this webinar, experts in oncology and gender-affirming care are discussing two clinical cases, providing their insights in the considerations that need to be made. 

Learning Objectives: 

1. Appraise current data on cancer risk with gender-affirming hormone therapy.
2. Summarize therapeutic approaches for gender affirmation in transgender patients who are diagnosed with sex-hormone sensitive cancers.
3. Contrast post-cancer diagnosis sex hormone management in cisgender people from management in transgender and gender diverse people.

Member-Exclusive Virtual Town Hall: Hormone Therapy in Non-binary and Genderqueer Individuals

Date: Jan 18, 2024 
Time: 2:30-4:00 PM ET 

Moderator: Koen Dreijerink, MD, PhD 

Speakers: 

• Thomas Steensma, PhD: The Non-Binary Genderqueer Spectrum 
• Tish Villanueva MD, MS: Case presentation: Options for estrogen treatment without breast development 
• Ole-Petter Hamnvik, MB BCh BAO, MMSc, MRCPI: Case presentation: Use of 5 alpha reductase inhibitors in addition to testosterone  

Description: The aim of this town hall is to learn about the NBGQ spectrum and to discuss experiences and challenges in treating NBGQ individuals, with the help of experts in the field. 

Learning Objectives: 

1. To be informed about the NBGQ spectrum 
2. To learn about possibilities and limitations with regard to tailoring feminizing hormone therapy 
3. To learn about possibilities and limitations with regard to partially antagonizing masculinizing hormone therapy 

Transgender Health Update: WPATH Standards of Care 8

May 8, 2023

Faculty: 
Michael Irwig, MD
Endocrinologist, Beth Israel Deaconess Medical Center 
Associate Professor, Harvard Medical School

Joshua Safer, MD
Associate Professor, Icahn School of Medicine at Mount Sinai
Executive Director, Mount Sinai Center for Transgender Medicine

Vin Tangpricha, MD, PhD
Endocrinologist, Emory University School of Medicine
Program Director, Emory Endocrinology Fellowship Program 

Learning Objectives:

• Develop a strategy for monitoring adults on gender-affirming hormone therapy
• Recognize the onset and time course of the effects of gender-affirming hormone therapy
• Appreciate the role of multidisciplinary care for transgender patient.

View Recording

The Common Intersection of Autism/Neurodivergence and Gender Diversity: Practical Skills for Endocrinologists

April 11, 2023

Speaker:

John Strang, PSYD
Pediatric Neuropsychologist 
Children’s National Hospital 

Moderators:
Jessica Abramowitz, MD
Associate Professor 
UT Southwestern Medical Center

Ole-Petter Hamnvik, MBBCH, BAO 
Program Director, Endocrinology Fellowship 
Brigham and Women’s Hospital 

This learning session focuses on the common intersection of gender diversity and neurodivergence/neurodiversity. Particular emphasis will be given to specialized clinical needs of transgender clients who are autistic or who have ADHD. Three primary learning objectives target interpersonal clinical skills for endocrinologists working with neurodivergent gender-diverse clients:

• This session will provide an overview of autism, ADHD, and their common overlap with gender diversity. Informed consent and clinical decision-making in the context of neurodivergence/autism will be explored.
• Learners will gain practical skills for supporting successful communication with neurodivergent transgender clients.
• Executive function accommodations for clients with challenges in the areas of organization, planning, future thinking, keeping appointments, and clinical follow-through will be discussed.

View Recording

The Transgender Research and Medicine SIG held an August 10, 2022 webinar on cancer screening in gender minorities. Attendees received an overview of preventative care disparities in gender diverse populations and an update on screening guideline recommendations. Breast, cervical, anal, and prostate cancers will be highlighted in this session. 

Speakers: 

• Michelle Cordoba Kissee, MD. Endocrinologist, Bariatric and Metabolic Institute at Renaissance
• Ole-Petter Hamnvik, MB BCh BAO, MMSc, MRCPI, Program Director, Endocrinology Fellowship, Brigham and Women’s Hospital, Assistant Professor of Medicine, Harvard Medical School

Learning objectives: 

• Recognize disparities in cancer prevalence and screening rates in transgender and gender diverse populations.
• Summarize available data on prevalence of key cancers in transgender and gender-diverse people.
• Choose appropriate cancer screening strategies based on organs at risk and hormonal milieu.

View Recording

Gender-Affirming Therapy and Bone Health 

The Transgender Research and Medicine SIG held a webinar on Gender-Affirming Therapy and Bone Health on November 9, 2021.

Speakers:

• Vin Tangpricha, MD, PhD, Professor of Medicine, Emory University School of Medicine , Staff Physician, Atlanta VA Medical Center
• Radhika Narla , MD, Assistant Professor Medicine, Fellowship Program VA Site Coordinator, University of Washington

View Recording

Hormones and Breast Health 

Transgender Research and Medicine SIG held a webinar on hormones and breast health on October 25, 2021 

Speaker: Tamar Reisman, MD, Assistant Professor of Medicine, Icahn School of Medicine at Mount Sinai

Learning Objectives:

• Describe hormonal influence on breast development. 
• Review breast cancer screening techniques and recommendations.
• Encourage discussion about the extent to which our current understanding of the above in cisgender individuals may or may not apply to the transgender persons. 

View Recording

SOGI Collection for Medical Purposes 

Speakers: Madeline Deutsch, MD, MPH, University of California San Francisco Health; Chris Grasso, MPH, Fenway Health Join the Transgender Research and Medicine Special Interest Group for a webinar on SOGI collection for medical purposes.

Learning Objectives: 

• Participants will be able to describe methods to actively engage and educate staff on the importance of collecting SOI data and how to do so, and its impact on health disparities
• Participants will be able to describe the impact SOGI data collection will have on key stakeholders (patients, staff, and management)
• Participants will be able to describe how the customization to an EHR can improve communication, data and quality management activities including the collection and reporting of patient-level information, clinical outcomes and better care coordination.

View Recording

Transgender Research and Medicine Special Interest Group Networking Event at ENDO 2021

Date: March 23,2021
Co-Chairs: Sean Iwamoto, MD,Caroline Davidge-Pitts, MBBCH

Join the Transgender Research and Medicine Special Interest Group for exciting small group discussions about this exciting and evolving field. Attendees of this session are invited to network and share their insights with colleagues interested in transgender research and medicine. The event will feature small group discussions based on interest and expertise- clinicians, educators, pediatricians, researchers, and those with public policy interests are all encouraged to attend.

The Transgender Research and Medicine Special Interest Group held a webinar on issues around transgender health and aging. This webinar has been designated for 1 AMA PRA Category 1 Credit™.

Faculty:

Amy Diesburg-Stanwood, DNP, FNP-BC
Minneapolis VA Medical Center

Sean Iwamoto, MD
University of Colorado School of Medicine, Rocky Mountain Regional VA Medical Center, UCHealth Integrated Transgender Program

Micol Rothman, MD (Moderator) 
University of Colorado School of Medicine and UCHealth Integrated Transgender Program

Karyne Vinales, MD 
Phoenix VA Medical Center, University of Arizona College of Medicine

View Recording

Tune into this webinar to learn more about the principles, risks and benefits of gender affirming hormone replacement therapy (HRT) and understand the informed consent and risk reduction models. By the end of this webinar, participants will be prepared to appropriately initiate and monitor gender affirming hormone replacement therapy in uncomplicated patients.

Faculty:

Speakers: Siham Accacha, MD
NYU Langone Health System

Michelle Cordoba Kissee, MD
Bariatric and Metabolic Institute at Renaissance

Isha Mittal, MPH, Medical Student
University of Texas Rio Grande Valley

Ashton Santo, MSW Candidate
Silberman School of Social Work

Tune into this webinar to explore the role of 5 alpha reductase inhibitors in gender diverse (trans and non-binary) individuals.

Faculty:

Moderator: Micol Rothman, MD
Associate Professor of Medicine and Radiology
University of Colorado School of Medicine
Co-Founder UC Health Integrated Transgender Program

Speaker: Michael S. Irwig, MD
Attending Physician
Beth Israel Deaconess Medical Center

Transgender Research and Medicine SIG webinar on November 3, 2022 provided overview on process of providing gender-affirming care to transgender adolescents.

Speakers:

Siham Accacha, MD
Director, Pediatric Diabetes Program
Pediatric Associate
Associate Professor of Clinical Pediatrics
NYU Langone Health
NYU School of Medicine, Langone Long Island

Melissa Dundas, MD, FAAP
Clinical Assistant Professor
Adolescent Medicine Physician
NYU Grossman School of Medicine
Bellvue Hospital

Moderator:

Karyne Lima Vinales, MD
Endocrinologist
Phoenix VA Healthcare System

Learning Objectives:

• Discuss the importance of providing gender affirming medical care.
• Explain the process to initiating hormone therapy.
• Describe different methods of medical interventions.

View Recording

Progress in Transgender Health Research: Year in Review 

The Transgender Research and Medicine SIG webinar on April 21, 2022 reviewed important studies in the previous year of transgender health research. Guest speakers discussed how researchers can be more inclusive of transgender communities moving forward.

Speakers:
Justine Defreyne, MD, PhD, Ghent University Hospital
Carl Streed, MPH, MD Boston University School of Medicine

Moderator:
Caroline Davidge-Pitts, MB, B.Ch

Learning Objectives:

• Understand trends in transgender health research funding and support.
• Discuss community-informed and led research best practices in transgender medicine.
• Gain an overview of the latest findings in clinical practice.

View Recording